These findings suggested that linc01014 could significantly regulate the activity of PI3K/Akt/mTOR signalling pathway via regulating the expression of PIK3CA to altering the sensitivity of ESCC cells to gefitinib. This evidence concerns the gene PIK3CA and esophageal squamous cell carcinoma.